Sodium voltage-gated channel alpha subunit 9
Sodium Voltage-Gated Channel Alpha Subunit 9[edit | edit source]
The sodium voltage-gated channel alpha subunit 9, also known as Nav1.7, is a protein that in humans is encoded by the SCN9A gene. This protein is a part of the voltage-gated sodium channel family, which is crucial for the initiation and propagation of action potentials in neurons.
Structure[edit | edit source]
Nav1.7 is a transmembrane protein that forms a pore through which sodium ions can pass. It is composed of four homologous domains, each containing six transmembrane segments. The fourth segment in each domain acts as the voltage sensor, while the loop between the fifth and sixth segments forms the ion-conducting pore.
Function[edit | edit source]
Nav1.7 channels are primarily expressed in the peripheral nervous system, particularly in nociceptors, which are sensory neurons responsible for the detection of painful stimuli. These channels play a critical role in the generation and conduction of action potentials in response to noxious stimuli, thus contributing to the sensation of pain.
Clinical Significance[edit | edit source]
Mutations in the SCN9A gene can lead to a variety of pain disorders. Gain-of-function mutations are associated with conditions such as primary erythromelalgia and paroxysmal extreme pain disorder, where patients experience episodes of severe pain. Conversely, loss-of-function mutations can result in congenital insensitivity to pain, a condition where individuals cannot feel pain, leading to an increased risk of injury.
Pharmacology[edit | edit source]
Nav1.7 is a target for the development of new analgesic drugs. Selective blockers of this channel are being investigated as potential treatments for chronic pain conditions, as they may provide pain relief without the side effects associated with traditional pain medications like opioids.
Research[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms by which Nav1.7 contributes to pain signaling and how it can be modulated to treat pain. Structural studies, such as those using cryo-electron microscopy, have provided detailed insights into the channel's architecture, aiding in the design of specific inhibitors.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD